FINWIRES · TerminalLIVE
FINWIRES

Impact Therapeutics Nets HK$759.5 Million From Hong Kong IPO Ahead of Debut

By

Impact Therapeutics (HKG:7630) raised HK$759.5 million in net proceeds from its initial public offering in Hong Kong.

The final offer price was set at HK$20.10 per H-share, near the lower end of the offer price range, according to a Tuesday after-market filing with the Hong Kong Stock Exchange.

The Chinese biotech company offered nearly 42 million H-shares in the global offering.

The Hong Kong public offer was 2,282.4 times subscribed, with a final allocation of 4.2 million shares, representing 10% of the total offering.

The international offering was 24.58 times subscribed, with a final allocation of 37.8 million shares, or 90% of the total offering.

An over-allocation of 6.3 million shares was made under the global offering.

Cornerstone investors, including Nanjing Biotech and Pharmaceutical Valley Construction and Development, Huang River Investment, and LAV Star, were allocated about 13.9 million shares representing 33.19% of the global offering, according to the filing.

Impact Therapeutics is scheduled to debut on the Hong Kong bourse on Wednesday, May 13.

Related Articles

Asia

Prospect Resources Starts Phase Three Drilling Program at Zambia Project

Prospect Resources (ASX:PSC) started its third-phase drilling program at the Mumbezhi project in Zambia, comprising roughly 60 diamond core holes, 30 reverse circulation holes, and 320 scout air-core holes, according to a Wednesday filing with the Australian bourse.The program, which covers about 26,000 meters of drilling, will target extension of the current indicated and inferred Mumbezhi mineral resource and maiden resources in key prospect areas, the filing said.Test work programs have been scheduled to support an initial scoping study for the project slated for the year-end, per the filing.

$ASX:PSC
Asia

Element 25 Advances Works at Western Australia Expansion Project

Element 25 (ASX:E25) advanced works at its Butcherbird expansion project in Western Australia, targeting manganese concentrate production of 1.1 million tonnes per year, according to a Wednesday filing with the Australian bourse.Orders for most main plant items, including the crushing circuit, conveyors, stackers, thickener, screens, and apron feeder, have been placed to minimize the risk of cost escalation, the filing said.Talks with preferred ore offtake partners are in progress, while contracts for mining services, haulage, and site services are nearing completion.The project is on track for mechanical completion and commissioning in the first quarter of 2027, per the filing.

$ASX:E25
Asia

5E Advanced Metals Signs 10-Year Offtake Agreement With Industrial Customer

5E Advanced Metals (ASX:5EA) signed 10-year offtake heads of agreement with an unnamed industrial customer, according to a Wednesday filing with the Australian bourse.The agreement serves as a foundation for the bankability of 5E Advanced Metals' Fort Cady project in California and shows that its boric acid meets the quality demands of industry end users, the company said.5E Advanced Metals aims to sign more offtake agreements over the coming weeks and months following a roadshow during which it met with a dozen potential customers.

$ASX:5EA